Prostate Cancer

Screening should begin:

• Canadian Urological Association [2022]
  • 45 years old for:
    • Men with a family history of prostate cancer in a first- or second-degree relative
  • 50 years old for:
    • Average risk men
• American Cancer Society
  • 40 years old for:
    • Men with more than one first-degree relative who had prostate cancer earlier than age 65
  • 45 years old for:
    • African Americans
    • Men with a first-degree relative (father or brother) diagnosed with prostate cancer earlier than age 65
  • 50 years old for:
    • Men at average risk

 

Screening intervals should be:

• Canadian Urological Association [2022]
  • Individualized based on previous PSA levels 
• American Cancer Society [2023]
  • If PSA <2.5 ng/mL: every 2 years
  • If PSA >2.5 ng/mL: annually

 

Screening should end:

• Canadian Urological Association [2022]
  • 70 years old
• American Cancer Society [2023]
  • ​When life expectancy is not greater than 10 years

 

Seel also:

• Comparison table of multiple guidelines

 

Content on this page has not been checked for accuracy. The author's credentials have not been confirmed. Always use multiple peer-reviewed scholarly sources and good clinical judgement in your decision making.

The Compendium platform was created by David Kwinter, MD, CCFP(EM).